北京:50家便利店试点销售乙类非处方药

2019-03-21 王薇 北京青年报

昨天,北京市召开全市市场监督管理工作会议。北京青年报记者从工作会上获悉,今年北京市将积极支持生活性服务业发展,扩大“一区一照”适用范围,探索实施“一市一照”。

昨天,北京市召开全市市场监督管理工作会议。北京青年报记者从工作会上获悉,今年北京市将积极支持生活性服务业发展,扩大“一区一照”适用范围,探索实施“一市一照”。

据了解,今年北京市将继续深化商事制度改革,打造更加宽松便捷的营商环境。实现企业开办“一天领照、三天办好”。深化“证照分离”“多证合一”改革,解决“准入不准营”问题。大力推进电子营业执照广泛应用。推动实施注销便利化改革,完善简易注销制度,将注销公告时间由45天缩短到20天。

2018年,北京市为满足群众便利性、宜居性、多样性需求,原市工商局、原市商务委等部门对纳入试点范围的17家连锁便利店试行“一区一照”登记管理。这些连锁便利店在一个区开办多家连锁店时,只需要在该区办理一张营业执照即可,其他门店的名称和经营场所同步登记在同一张营业执照上。今年北京市将积极支持生活性服务业发展,扩大“一区一照”适用范围,探索实施“一市一照”。

北青报记者了解到,今年北京市还将进一步简政放权,深化推进许可审批改革。在市场监管部门内部,全面探索实施许可办理“先证后核”“告知承诺”,稳妥下放行政事项办理权限,推行全程电子化办理,实现线上“一网通办”、线下“只进一扇门”“一窗受理”、企业和群众办事“最多跑一次”。今年北京市还将在50家连锁便利店试点乙类非处方药、二类医疗器械销售服务。

另据介绍,今年北京市还将深化市场监管风险洞察平台应用,为分级分类监管赋能增效。制定实施加强企业信用体系建设第三阶段行动计划,升级北京市企业信用信息网,健全信用联合惩戒和信用修复机制,推动信用信息数据归集开放共享。坚持公正监管与包容审慎监管结合,支持新业态新模式健康发展。

在执法方面,深入推进市场监管综合行政执法改革,严惩侵犯知识产权和制售假冒伪劣商品、垄断、不正当竞争、违规直销、虚假违法广告、食品药品违法、网络违法、价格违法等各类违法行为,让违法者付出付不起的代价。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
    2019-05-23 mfx799
  6. [GetPortalCommentsPageByObjectIdResponse(id=1687332, encodeId=8220168e332b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Mon Apr 22 00:31:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819210, encodeId=42f718192108c, content=<a href='/topic/show?id=0805993615a' target=_blank style='color:#2F92EE;'>#非处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99361, encryptionId=0805993615a, topicName=非处方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 30 12:31:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763382, encodeId=b6271e633821d, content=<a href='/topic/show?id=14ae2e03548' target=_blank style='color:#2F92EE;'>#便利店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27035, encryptionId=14ae2e03548, topicName=便利店)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9a37514884, createdName=ms920641618706883, createdTime=Sun Feb 23 10:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641707, encodeId=29c11641e07e5, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Dec 05 14:31:00 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033637, encodeId=2dd1203363e44, content=<a href='/topic/show?id=2aa91433ab' target=_blank style='color:#2F92EE;'>#50家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1433, encryptionId=2aa91433ab, topicName=50家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu May 23 13:31:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589656, encodeId=e634158965608, content=<a href='/topic/show?id=10f299362a1' target=_blank style='color:#2F92EE;'>#非处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99362, encryptionId=10f299362a1, topicName=非处方药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=716117772264, createdName=gracezdd, createdTime=Sat Mar 23 01:31:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]

相关资讯

北京便利店里可买药:需配备药师进行用药指导

昨日上午,位于工体东路的京客隆便利店的收银台后新增了三个特殊的货架,上面放着70多种非处方药品和医疗器械,包括感冒药、医用酒精、退烧贴等常见药品和医疗器械。北京青年报记者了解到,这是本市首个获批经营药品、医疗器械的便利店。北青报记者了解到,允许便利店按有关标准申请零售经营乙类非处方药、二类医疗器械是北京市近日出台的《关于进一步促进便利店发展的若干措施》(以下简称《措施》)中的新举措。这一政策打破之

JAHA:住处周边便利店比例与冠脉钙化的发生呈相关性!

既往研究报道周边环境与亚临床动脉粥样硬化呈相关性,本研究的目的旨在评估有更多“不健康”食品环境的社区是否与冠脉钙化(CAC)的发展相关。本研究纳入了CARDIA 临床研究中的2706名接受有CAC检测的患者,患者的周边环境特征包括住处3km内所有与食物相关的场所包括便利店和快餐店。基线水平,有9.7%的患者检测出CAC,经过10年的随访,21.1%的患者发展为CAC,便利店占比每增加1个SD,CA